{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T06:54:43Z","timestamp":1782284083205,"version":"3.54.5"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,1,20]],"date-time":"2010-01-20T00:00:00Z","timestamp":1263945600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s10552-010-9504-y","type":"journal-article","created":{"date-parts":[[2010,1,19]],"date-time":"2010-01-19T05:52:59Z","timestamp":1263880379000},"page":"759-769","source":"Crossref","is-referenced-by-count":34,"title":["Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma"],"prefix":"10.1007","volume":"21","author":[{"given":"Pia","family":"Fernberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen T.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Duvefelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Hjalgrim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Eloranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina Meden","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Porwit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Humphreys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads","family":"Melbye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Ekstr\u00f6m Smedby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,1,20]]},"reference":[{"issue":"Suppl 12","key":"9504_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.22719","volume":"120","author":"DD Alexander","year":"2007","unstructured":"Alexander DD, Mink PJ, Adami HO et al (2007) The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer 120(Suppl 12):1\u201339","journal-title":"Int J Cancer"},{"key":"9504_CR2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/02841860500531682","volume":"45","author":"K Ekstrom-Smedby","year":"2006","unstructured":"Ekstrom-Smedby K (2006) Epidemiology and etiology of non-Hodgkin lymphoma\u2014a review. Acta Oncol 45:258\u2013271","journal-title":"Acta Oncol"},{"key":"9504_CR3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1008853421083","volume":"9","author":"K Zhu","year":"1998","unstructured":"Zhu K, Levine RS, Gu Y et al (1998) Non-Hodgkin\u2019s lymphoma and family history of malignant tumors in a case-control study (United States). Cancer Causes Control 9:77\u201382","journal-title":"Cancer Causes Control"},{"key":"9504_CR4","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1002\/cncr.20189","volume":"100","author":"LR Goldin","year":"2004","unstructured":"Goldin LR, Pfeiffer RM, Gridley G et al (2004) Familial aggregation of Hodgkin lymphoma and related tumors. Cancer 100:1902\u20131908","journal-title":"Cancer"},{"key":"9504_CR5","doi-asserted-by":"crossref","first-page":"960","DOI":"10.3324\/haematol.11011","volume":"92","author":"CF Skibola","year":"2007","unstructured":"Skibola CF, Curry JD, Nieters A (2007) Genetic susceptibility to lymphoma. Haematologica 92:960\u2013969","journal-title":"Haematologica"},{"key":"9504_CR6","doi-asserted-by":"crossref","first-page":"e2816","DOI":"10.1371\/journal.pone.0002816","volume":"3","author":"CF Skibola","year":"2008","unstructured":"Skibola CF, Bracci PM, Halperin E et al (2008) Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma. PLoS ONE 3:e2816","journal-title":"PLoS ONE"},{"key":"9504_CR7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1470-2045(05)70434-4","volume":"7","author":"N Rothman","year":"2006","unstructured":"Rothman N, Skibola CF, Wang SS et al (2006) Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol 7:27\u201338","journal-title":"Lancet Oncol"},{"key":"9504_CR8","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1158\/0008-5472.CAN-06-4752","volume":"67","author":"SS Wang","year":"2007","unstructured":"Wang SS, Cozen W, Cerhan JR et al (2007) Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. Cancer Res 67:5042\u20135054","journal-title":"Cancer Res"},{"key":"9504_CR9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1600-0609.2006.00784.x","volume":"78","author":"B Bel Hadj Jrad","year":"2007","unstructured":"Bel Hadj Jrad B, Chatti A, Laatiri A et al (2007) Tumor necrosis factor promoter gene polymorphism associated with increased susceptibility to non-Hodgkin\u2019s lymphomas. Eur J Haematol 78:117\u2013122","journal-title":"Eur J Haematol"},{"key":"9504_CR10","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/carcin\/bgl200","volume":"28","author":"MP Purdue","year":"2007","unstructured":"Purdue MP, Lan Q, Kricker A et al (2007) Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study. Carcinogenesis 28:704\u2013712","journal-title":"Carcinogenesis"},{"key":"9504_CR11","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.1158\/0008-5472.CAN-06-0324","volume":"66","author":"SS Wang","year":"2006","unstructured":"Wang SS, Cerhan JR, Hartge P et al (2006) Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Res 66:9771\u20139780","journal-title":"Cancer Res"},{"key":"9504_CR12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2141.2006.06030.x","volume":"133","author":"CF Spink","year":"2006","unstructured":"Spink CF, Keen LJ, Mensah FK et al (2006) Association between non-Hodgkin lymphoma and haplotypes in the TNF region. Br J Haematol 133:293\u2013300","journal-title":"Br J Haematol"},{"key":"9504_CR13","doi-asserted-by":"crossref","first-page":"e5360","DOI":"10.1371\/journal.pone.0005360","volume":"4","author":"SS Wang","year":"2009","unstructured":"Wang SS, Purdue MP, Cerhan JR et al (2009) Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk. PLoS ONE 4:e5360","journal-title":"PLoS ONE"},{"key":"9504_CR14","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nri1703","volume":"5","author":"M Karin","year":"2005","unstructured":"Karin M, Greten FR (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5:749\u2013759","journal-title":"Nat Rev Immunol"},{"key":"9504_CR15","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","volume":"19","author":"KW Moore","year":"2001","unstructured":"Moore KW, de Waal Malefyt R, Coffman RL, O\u2019Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683\u2013765","journal-title":"Annu Rev Immunol"},{"key":"9504_CR16","unstructured":"Jaffe ES HN, Stein H, Vardiman JW editors (2001) WHO classification of tumours: pathology and genetics of tumours of hematopoietic and lymphoid tissues, Lyon, France. International Agency for Research on Cancer Press"},{"key":"9504_CR17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0002-9440(10)63284-1","volume":"165","author":"J Iqbal","year":"2004","unstructured":"Iqbal J, Sanger WG, Horsman DE et al (2004) BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. Am J Pathol 165:159\u2013166","journal-title":"Am J Pathol"},{"key":"9504_CR18","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1182\/blood.V99.7.2285","volume":"99","author":"JZ Huang","year":"2002","unstructured":"Huang JZ, Sanger WG, Greiner TC et al (2002) The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. Blood 99:2285\u20132290","journal-title":"Blood"},{"key":"9504_CR19","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s00428-003-0809-z","volume":"442","author":"R Kodet","year":"2003","unstructured":"Kodet R, Mrhalova M, Krskova L et al (2003) Mantle cell lymphoma: improved diagnostics using a combined approach of immunohistochemistry and identification of t(11;14)(q13;q32) by polymerase chain reaction and fluorescence in situ hybridization. Virchows Arch 442:538\u2013547","journal-title":"Virchows Arch"},{"key":"9504_CR20","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.3109\/10428190109097730","volume":"42","author":"C Kawasaki","year":"2001","unstructured":"Kawasaki C, Ohshim K, Suzumiya J et al (2001) Rearrangements of bcl-1, bcl-2, bcl-6, and c-myc in diffuse large B-cell lymphomas. Leuk Lymphoma 42:1099\u20131106","journal-title":"Leuk Lymphoma"},{"key":"9504_CR21","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1126\/science.6356357","volume":"222","author":"P Leder","year":"1983","unstructured":"Leder P, Battey J, Lenoir G et al (1983) Translocations among antibody genes in human cancer. Science 222:765\u2013771","journal-title":"Science"},{"key":"9504_CR22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00439-006-0212-3","volume":"120","author":"SS Wang","year":"2006","unstructured":"Wang SS, Cozen W, Severson RK et al (2006) Cyclin D1 splice variant and risk for non-Hodgkin lymphoma. Hum Genet 120:297\u2013300","journal-title":"Hum Genet"},{"key":"9504_CR23","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/jnci\/dji344","volume":"97","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, Lan Q, Rothman N et al (2005) A putative exonic splicing polymorphism in the BCL6 gene and the risk of non-Hodgkin lymphoma. J Natl Cancer Inst 97:1616\u20131618","journal-title":"J Natl Cancer Inst"},{"key":"9504_CR24","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1158\/1055-9965.EPI-08-1037","volume":"18","author":"LM Morton","year":"2009","unstructured":"Morton LM, Purdue MP, Zheng T et al (2009) Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development. Cancer Epidemiol Biomarkers Prev 18:1259\u20131270","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9504_CR25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1084\/jem.164.1.315","volume":"164","author":"ML Cleary","year":"1986","unstructured":"Cleary ML, Galili N, Sklar J (1986) Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas. J Exp Med 164:315\u2013320","journal-title":"J Exp Med"},{"key":"9504_CR26","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/315340a0","volume":"315","author":"Y Tsujimoto","year":"1985","unstructured":"Tsujimoto Y, Jaffe E, Cossman J et al (1985) Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Nature 315:340\u2013343","journal-title":"Nature"},{"key":"9504_CR27","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1200\/JCO.2005.26.856","volume":"23","author":"D Jong de","year":"2005","unstructured":"de Jong D (2005) Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors. J Clin Oncol 23:6358\u20136363","journal-title":"J Clin Oncol"},{"key":"9504_CR28","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1182\/blood.V80.4.879.879","volume":"80","author":"SJ Korsmeyer","year":"1992","unstructured":"Korsmeyer SJ (1992) Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 80:879\u2013886","journal-title":"Blood"},{"key":"9504_CR29","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/bjc.1997.279","volume":"75","author":"M Butler","year":"1997","unstructured":"Butler M, Corbally N, Dervan PA, Carney DN (1997) BCL-6 and other genomic alterations in non-Hodgkin\u2019s lymphoma (NHL). Br J Cancer 75:1641\u20131645","journal-title":"Br J Cancer"},{"key":"9504_CR30","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/335440a0","volume":"335","author":"DL Vaux","year":"1988","unstructured":"Vaux DL, Cory S, Adams JM (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440\u2013442","journal-title":"Nature"},{"key":"9504_CR31","first-page":"4608","volume":"57","author":"MH Dreyling","year":"1997","unstructured":"Dreyling MH, Bullinger L, Ott G et al (1997) Alterations of the cyclin D1\/p16-pRB pathway in mantle cell lymphoma. Cancer Res 57:4608\u20134614","journal-title":"Cancer Res"},{"key":"9504_CR32","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2796.2008.02029.x","volume":"264","author":"KE Smedby","year":"2008","unstructured":"Smedby KE, Askling J, Mariette X, Baecklund E (2008) Autoimmune and inflammatory disorders and risk of malignant lymphomas\u2014an update. J Intern Med 264:514\u2013527","journal-title":"J Intern Med"},{"key":"9504_CR33","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","volume":"54","author":"E Baecklund","year":"2006","unstructured":"Baecklund E, Iliadou A, Askling J et al (2006) Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 54:692\u2013701","journal-title":"Arthritis Rheum"},{"key":"9504_CR34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/jnci\/dji022","volume":"97","author":"KE Smedby","year":"2005","unstructured":"Smedby KE, Hjalgrim H, Melbye M et al (2005) Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 97:199\u2013209","journal-title":"J Natl Cancer Inst"},{"key":"9504_CR35","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/0277-5379(91)90081-N","volume":"27","author":"F d\u2019Amore","year":"1991","unstructured":"d\u2019Amore F, Christensen BE, Brincker H et al (1991) Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Danish LYFO Study Group. Eur J Cancer 27:1201\u20131208","journal-title":"Eur J Cancer"},{"key":"9504_CR36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/gte.2006.0503","volume":"11","author":"KM Sorensen","year":"2007","unstructured":"Sorensen KM, Jespersgaard C, Vuust J et al (2007) Whole genome amplification on DNA from filter paper blood spot samples: an evaluation of selected systems. Genet Test 11:65\u201371","journal-title":"Genet Test"},{"key":"9504_CR37","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1093\/nar\/gkl1152","volume":"35","author":"L Milani","year":"2007","unstructured":"Milani L, Gupta M, Andersen M et al (2007) Allelic imbalance in gene expression as a guide to cis-acting regulatory single nucleotide polymorphisms in cancer cells. Nucleic Acids Res 35:e34","journal-title":"Nucleic Acids Res"},{"key":"9504_CR38","first-page":"563","volume":"86","author":"D Howe","year":"2001","unstructured":"Howe D, Lynas C (2001) The cyclin D1 alternative transcripts [a] and [b] are expressed in normal and malignant lymphocytes and their relative levels are influenced by the polymorphism at codon 241. Haematologica 86:563\u2013569","journal-title":"Haematologica"},{"key":"9504_CR39","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/ijc.21225","volume":"117","author":"M Wirtenberger","year":"2005","unstructured":"Wirtenberger M, Hemminki K, Forsti A et al (2005) c-MYC Asn11Ser is associated with increased risk for familial breast cancer. Int J Cancer 117:638\u2013642","journal-title":"Int J Cancer"},{"key":"9504_CR40","first-page":"179","volume":"187","author":"C Jurinke","year":"2002","unstructured":"Jurinke C, van den Boom D, Cantor CR, Koster H (2002) Automated genotyping using the DNA MassArray technology. Methods Mol Biol 187:179\u2013192","journal-title":"Methods Mol Biol"},{"key":"9504_CR41","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/ng1100","volume":"33","author":"MS Phillips","year":"2003","unstructured":"Phillips MS, Lawrence R, Sachidanandam R et al (2003) Chromosome-wide distribution of haplotype blocks and the role of recombination hot spots. Nat Genet 33:382\u2013387","journal-title":"Nat Genet"},{"key":"9504_CR42","first-page":"35","volume":"NS20","author":"JF Emigh","year":"1980","unstructured":"Emigh JF (1980) Pharmacy\u2019s glaucoma alert. Am Pharm NS20:35\u201336","journal-title":"Am Pharm"},{"key":"9504_CR43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jnci\/djj004","volume":"98","author":"KE Smedby","year":"2006","unstructured":"Smedby KE, Hjalgrim H, Askling J et al (2006) Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 98:51\u201360","journal-title":"J Natl Cancer Inst"},{"key":"9504_CR44","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/gepi.20032","volume":"27","author":"D Clayton","year":"2004","unstructured":"Clayton D, Chapman J, Cooper J (2004) Use of unphased multilocus genotype data in indirect association studies. Genet Epidemiol 27:415\u2013428","journal-title":"Genet Epidemiol"},{"key":"9504_CR45","first-page":"143","volume":"184","author":"PH Westfall","year":"2002","unstructured":"Westfall PH, Zaykin DV, Young SS (2002) Multiple tests for genetic effects in association studies. Methods Mol Biol 184:143\u2013168","journal-title":"Methods Mol Biol"},{"key":"9504_CR46","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/jnci\/djh075","volume":"96","author":"S Wacholder","year":"2004","unstructured":"Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96:434\u2013442","journal-title":"J Natl Cancer Inst"},{"key":"9504_CR47","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1182\/blood-2007-09-112144","volume":"111","author":"CF Skibola","year":"2008","unstructured":"Skibola CF, Nieters A, Bracci PM et al (2008) A functional TNFRSF5 gene variant is associated with risk of lymphoma. Blood 111:4348\u20134354","journal-title":"Blood"},{"key":"9504_CR48","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1158\/1055-9965.EPI-08-0536","volume":"17","author":"JR Cerhan","year":"2008","unstructured":"Cerhan JR, Liu-Mares W, Fredericksen ZS et al (2008) Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin\u2019s lymphoma. Cancer Epidemiol Biomarkers Prev 17:3161\u20133169","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9504_CR49","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.canlet.2005.07.015","volume":"238","author":"S Susova","year":"2006","unstructured":"Susova S, Trneny M, Soucek P (2006) Single nucleotide polymorphism in 5\u2032-flanking region of BCL6 is not associated with increased risk of non-Hodgkin\u2019s lymphoma. Cancer Lett 238:142\u2013145","journal-title":"Cancer Lett"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-010-9504-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-010-9504-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-010-9504-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T23:37:37Z","timestamp":1711150657000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-010-9504-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,20]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["9504"],"URL":"https:\/\/doi.org\/10.1007\/s10552-010-9504-y","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,20]]}}}